Avicor, reported by HVG (Weekly World Economy) the Hungarian leading economic and political weekly, is working on synthetizing potential drug candidate molecules which inhibit the enzyme responsible for the viral entry of Covid-19 together with a German company.

Avicor Ltd. successfully developed several new products in the frame of a Hungarian R&D grant (KFI_16-1-2017-0105) for specific enrichment of nucleic acids deriving from diverse biological samples specific for human, bacterial, fungal and viral nucleic acids.

Avicor at BIO 2019- Philadelphia, PA (June, 3-6 2019) Avidin’s CEO László Puskás and Klára Kitajka is participating at BIO 2019 .